Pharmacokinetic profile of ABELCET (amphotericin B lipid complex injection): combined experience from phase I and phase II studies.

Amphotericin B (AmB) has been the most effective systemic antifungal agent, but its use is limited by the dose-limiting toxicity of the conventional micellar dispersion formulation (Fungizone). New formulations with better and improved safety profiles are being developed and include ABELCET (formerl...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Adedoyin, A, Bernardo, J F, Swenson, C E, Bolsack, L E, Horwith, G, DeWit, S, Kelly, E, Klasterksy, J, Sculier, J P, DeValeriola, D, Anaissie, E, Lopez-Berestein, G, Llanos-Cuentas, A, Boyle, A, Branch, R A
Médium: Artigo
Jazyk:Inglês
Vydáno: 1997
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC164093/
https://ncbi.nlm.nih.gov/pubmed/9333048
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky